Good results, but we need at least one DEP license deal to restore the faith IMO.
The market isn't going crazy over the results ... we can't even hold $1 sadly ..... I guess we have seen so many of the same types of good reports for a number of DEP products that are still to go anywhere with partnership / license deals so no more of the usual excitement from announcements like this ?
People may even start to think that all these DEP projects may go nowhere like the eyedrops have in over a decade ... I would have thought if all these results were so good a big pharma would be jumping at the opportunity to reduce toxicity and extend or create new patents on already successful drugs - that is not the case yet so some must be wondering why ?
I guess @thrasher will be happy as he got his Thursday announcement
SPL Price at posting:
96.5¢ Sentiment: Hold Disclosure: Held
... I would have thought if all these results were so good a big pharma would be jumping at the opportunity to reduce toxicity and extend or create new patents on already successful drugs - that is not the case yet so some must be wondering why ?
